NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.
27d
Zacks Investment Research on MSNATRA Stock Down After FDA Issues CRL for Rare Blood Cancer CandidateShares of Atara Biotherapeutics ATRA plunged 40.5% on Thursday after the FDA issued a complete response letter (CRL) against the company’s biologics license application (BLA) seeking approval of lead ...
Check the time stamp on this data. Updated AI-Generated Signals for Atara Biotherapeutics Inc. (ATRA) available here: ATRA.
The testbed for the latest and greatest radar under development for the Eurofighter Typhoon is an unusual looking model of ...
Atara Biotherapeutics (ATRA) plans to cut around 50% of its workforce, just a little over a week after the FDA declined to approve its immunotherapy Ebvallo. Read more here.
Equities researchers at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for shares of Atara ...
Nevertheless, ATRA remains eligible for these future payments. This forced ATRA to suspend its CAR-T pipeline in search for strategic alternatives. On the bright side, this creates another short ...
Shares of Atara Biotherapeutics ATRA plunged 40.5% on Thursday after the FDA issued a complete response letter (CRL) against the company’s biologics license application (BLA) seeking approval of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results